Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
MicroRNA
66%
Myocardial Infarction
43%
Circulating microRNA
43%
MiR-122-5p
39%
COVID-19
39%
Acute Myocardial Infarction
37%
MiR-320a
26%
MiR-499
26%
Heart Failure
24%
Acute Chest Syndrome
23%
Diagnostic Value
23%
High-sensitivity Cardiac Troponin
23%
Prognostic Value
22%
Micra
19%
MiR-21-5p
19%
Cardiogenic Shock
19%
90-day Mortality
19%
Incremental Value
19%
Circular RNA
19%
Essential Hypertension
19%
MiR-144-3p
19%
MiR-144
19%
Neurological Complications
19%
Risk Stratification
19%
Long Non-coding RNA (LncRNA)
19%
Left Ventricular Hypertrophy
19%
Soluble Fms-like Tyrosine kinase-1 (sFlt-1)
19%
N6-methyladenosine
19%
Machine Learning Models
19%
Outcome Prediction
19%
Out-of-hospital Cardiac Arrest
19%
Cardiac Troponin
19%
Peripheral Blood
19%
Antisense Long Noncoding RNA
19%
Cardiovascular Complications
19%
LEF1
19%
PLBD1
19%
Transcriptome Microarray
19%
Quantitative PCR
19%
MiR-208a-3p
17%
Myocardial Infarction Patients
13%
95% Confidence Interval
13%
Support Vector Machine Model
11%
Hypertension Patients
11%
Clinical Risk Factors
11%
Post-myocardial Infarction Heart Failure
11%
Ejection Fraction
11%
Healthy Controls
10%
Final Diagnosis
9%
N-terminal pro-B-type Natriuretic Peptide (NT-proBNP)
9%
Biochemistry, Genetics and Molecular Biology
Heart Ventricle Function
84%
Long Non-Coding RNA
69%
MicroRNA
59%
Long Noncoding RNA
44%
Real-Time Polymerase Chain Reaction
38%
Brain Natriuretic Peptide
34%
Antisense
32%
Heart Ejection Fraction
31%
RNA
29%
Vascular Endothelial Growth Factor B
29%
Angiogenesis
26%
Transcriptome
24%
N-Terminus
24%
Macrophage
19%
Adenosine
19%
Peripheral Blood Mononuclear Cell
19%
Triadin
19%
Skeletal Muscle
19%
Heart Left Ventricle Contractility
19%
Epitranscriptomics
19%
N6-Methyladenosine
19%
Protein Microarray
19%
Fat Mass
19%
Reperfusion
15%
Protein-Protein Interaction Networks
13%
RNA Sequence
12%
Troponin T
12%
Normal Human
12%
KCNQ1OT1
12%
Gene Expression
12%
Support Vector Machine
11%
Non-Coding RNA
10%
Upregulation
10%
Heart Left Ventricle Ejection Fraction
9%
Antisense RNA
9%
Lymphoid Enhancer-Binding Factor 1
9%
Thrombospondin 1
9%
Placental Growth Factor
9%
Protein Interaction
9%
Protein Characterization
9%
RNA Modification
9%
Cell Growth
9%
Protein Expression
9%
Rat
9%
Molecular Mechanism
9%
Monocyte
9%
Chromatography
9%
Prognostic Biomarker
9%
Demethylase
9%
Mass Spectrometry
9%
Pharmacology, Toxicology and Pharmaceutical Science
microRNA
100%
Acute Heart Infarction
89%
Long Untranslated RNA
59%
Heart Infarction
58%
microRNA 122
49%
Circulating microRNA
46%
Biological Marker
46%
Congestive Heart Failure
45%
Heart Ventricle Remodeling
42%
Cardiogenic Shock
39%
Heart Left Ventricle Failure
24%
Adenosine
21%
Out of Hospital Cardiac Arrest
19%
Brain Natriuretic Peptide
19%
Heart Left Ventricle Hypertrophy
19%
Acute Heart Failure
19%
Vasculotropin
19%
Heart Arrest
19%
Essential Hypertension
19%
All Cause Mortality
14%
Heart Disease
14%
microRNA 16
9%
Lung Adenocarcinoma
8%
Complementary RNA
8%
Aortic Constriction
7%
Neuron Specific Enolase
7%
Receptor
6%
Acute Coronary Syndrome
6%
Gelatinase B
6%
Hypoxia Inducible Factor
6%
microRNA 101
6%
Alanine Aminotransferase
5%
Lactic Acid
5%
microRNA 124
5%
Untranslated RNA
5%